. Author manuscript; available in PMC: 2013 Jul 16.

Published in final edited form as: J Hum Hypertens. 2009 Jan 22;23(6):407–414. doi: 10.1038/jhh.2008.148

Table 1.

Baseline Characteristics^*

	All Subjects	Non-Diabetic	Diabetic
	(n=18)	(n=8)	(n=10)
Age (years)	23±4	23±3	23±5
Smoker n (%)	3 (17)	1 (13)	2 (20)
BMI (kg/m²)	25±4	25±6	25±3
MAP (mmHg)^†	83±6	84±5	83±6
Duration of Diabetes (years)	-	-	9.8±4.1
Hemoglobin A1c (%)	-	-	7.6±1.7
Ethinyl estradiol (µg/tablet)	32±5	33±3	31±6
Progestin (mg/tablet)	0.43±0.42	0.54±0.49	0.34±0.35
Progestational Activity (RBA)	0.71±0.52	0.79±0.59	0.64±0.48
Androgenic Activity (RBA)	0.75±0.56	0.75±0.67	0.74±0.48
PRA (ng Ang I/mL/h)	0.5±0.45	0.5±0.36	0.6±0.53
Fasting Serum Glucose (mg/dL) (mmol/L)	122±67 (6.8±3.7)	80±5 (4.4±0.3)	151±78 (8.4±4.3)
Urine Sodium (mmol/24h)	276±89	282±83	272±98
RPF (ml/min/1.73m²)^†	614±73	646±81	588±57
RVR (mmHg/mL/min/1.73m²)	85±11	81±11	88±10

Abbreviations: BMI, body mass index; MAP, mean arterial pressure; PRA, plasma rennin activity; Ang I, angiotensin I; RPF, renal plasma flow

Data are expressed as mean ± standard deviation unless otherwise indicated

^†

Median of readings at t = −10 min, −5 min and 0